Curve review
All doses cost the same, four terms are published, and coverage reaches every state.
The verdict
Curve publishes $175 a month for semaglutide and $225 for tirzepatide month to month, read August 2026, with all doses priced the same and coverage across fifty states.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- $175/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
Curve sells both molecules by injection across four commitment lengths. Every rung is published. Coverage is recorded in all fifty states.
Who writes the prescription, and what do they see?
A prescription precedes shipping and the pages describe plans rather than clinicians. The intake is not documented anywhere a reader can reach. What is documented is every price a reader might be charged.
Two disclosures do most of the work here. Doses are priced the same, and the full term ladder is printed rather than revealed at checkout. Together they mean a reader can compute a year before creating an account.
What happens when the dose goes up?
Curve states all doses are priced the same on both molecules, which answers the question directly. What it does not describe is any clinical support attached to an increase — the price behavior is settled and the care around the step is not.
What the price includes
Semaglutide is $175 month to month, $145 quarterly, $120 on six months and $99 on annual prepay. Tirzepatide runs $225, $199, $175 and $135. The annual rungs are 43% and 40% below the month-to-month rates, which is a wide spread and a long lock to earn it.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: All doses priced the same, both molecules
- Strength: Coverage across all fifty states
- Strength: Every term rung published up front
- Limitation: The lowest rates need annual prepay
- Limitation: No clinical detail on a dose increase
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Curve. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader in a thinly-served state who wants the rate pinned across a titration.
- Wrong for
- A reader unwilling to prepay a year for the lowest figure.
How Curve compares
| Seller | Who it suits | Go |
|---|---|---|
| Effecty | Readers ready to commit a year and wanting the rate fixed across it | See Effecty → |
| Elevated Health | Readers who want to see every rung before choosing a term | See Elevated Health → |
 DrBrainRx | Readers escalating to a high dose who want the rate pinned across it | See DrBrainRx → |
More GLP-1 telehealth sellers reviews: Go Vida PlenaGobyMedsGoldspan HealthGood Girl RxGood Life MedsGreen Cap Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Does the price change as my dose rises?
- No. Curve states all doses are priced the same on both molecules.
- What are the term rates?
- Semaglutide is $175 month to month, $145 quarterly, $120 on six months and $99 on annual prepay. Tirzepatide is $225, $199, $175 and $135.
- Where does Curve ship?
- All fifty states are recorded in its coverage list.
- Is Curve legit?
- Curve is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Curve expensive compared with other GLP-1 telehealth sellers?
- Curve publishes a starting figure of $175/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Curve below the median, toward the cheaper end. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.